24 studies found for:    Open Studies | "Encephalitis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Encephalitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
3 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
4 Not yet recruiting Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
5 Not yet recruiting 6-year Antibody Check After Third Vaccination Against Japanese Encephalitis
Condition: Post Other Specified Vaccination Encephalitis
Intervention: Other: Blood draw
6 Recruiting The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans
Conditions: Yellow Fever;   Encephalitis, Japanese
Interventions: Biological: Japanese Encephalitis vaccine;   Biological: Yellow Fever vaccine
7 Unknown  Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-immune
8 Recruiting Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
Condition: Tick Borne Encephalitis
Intervention: Biological: TBE virus vaccine
9 Recruiting Post-licensure Safety Study of IMOJEV® in Thailand
Condition: Japanese Encephalitis
Intervention: Biological: IMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine
10 Recruiting Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis
Condition: Anti-NMDA Receptor Encephalitis
Interventions: Device: tDCS;   Device: Sham Stimulation
11 Unknown  Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
12 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
13 Not yet recruiting B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.
Condition: Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)
Interventions: Drug: Rituximab;   Drug: Placebo
14 Recruiting Brain Inflammation and Function in Alcoholism
Condition: Alcoholism
Interventions: Device: MRI;   Drug: C-11PBR28;   Drug: F-18FDG
15 Recruiting Brain Inflammation in Major Depressive Disorder Background
Condition: Major Depression
Intervention:
16 Recruiting Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
17 Recruiting Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
18 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
19 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
20 Recruiting B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Rituximab

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years